{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Postdischarge Video-Based Virtual Visits vs. In-Person Follow-Up"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomised in a 2:1 ratio"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were those undergoing minimally invasive appendectomy or cholecystectomy. This randomised, active, controlled noninferiority trial was conducted in an urban setting, involving patients from a small community hospital and a large tertiary care hospital."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomised in a 2:1 ratio to receive either video-based virtual visits or in-person visits."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the outcomes of 30-day hospital encounters among patients receiving virtual follow-up compared to in-person follow-up."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the percentage of patients with a 30-day hospital encounter, defined as an emergency department visit, observation, or inpatient admission."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 432 patients were randomised, with 289 in the virtual group and 143 in the in-person group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was conducted on an intention-to-treat basis."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The hospital encounter rate was noninferior for virtual visits (12.8% vs. 13.3% for in-person, \u0394 0.5% with 1-sided 95% CI, \u2212\u221e to 5.2%)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov Identifier: NCT03258177"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}